Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Biotech/Pharma - Finance
Forendo Pharma Closes EUR 12 Million Series A Financing Round 10/22/2014 8:31:35 AM
Viamet Pharmaceuticals Reels In $60 Million Series D Financing 10/21/2014 5:38:42 AM
New Biotech, Unum Therapeutics, Launches In Cambridge With $12 Million In Pocket 10/21/2014 6:55:02 AM
David And Barbara Roux Provide Historic $10 Million Gift To Advance Genomic Medicine Research At The Jackson Laboratory 10/21/2014 12:05:15 PM
HEALTHSOUTH Declares Dividend On Common Stock And Dividend On 6.5% Series A Convertible Perpetual Preferred Stock 10/21/2014 8:54:24 AM
Biotech Startup Factory PureTech Nabs $55 Million 10/20/2014 6:34:23 AM
Canaan Closes $675 Million Fund With An Eye For Biotech And Medtech Startups 10/17/2014 6:12:18 AM
Highland Therapeutics Snags $25 Million Financing 10/16/2014 6:43:07 AM
Epigenomics AG Raises USD 5.3 Million From Its Strategic Commercialization Partner Biochain Institute, Inc. 10/16/2014 2:00:29 PM
Tetra Discovery Partners Announces Additional Financing And Formation Of Scientific Advisory Board 10/16/2014 7:59:13 AM
Relmada Therapeutics Reinforces Balance Sheet With $15.2 Million From Exercise Of Warrants 10/16/2014 6:40:51 AM
Zynerba Reels In $13 Million 10/15/2014 6:49:09 AM
Selecta Biosciences, Inc. Announces More Than $20 Million In Equity Funding 10/15/2014 6:29:47 AM
ContraVir Pharmaceuticals Closes $9.0 Million Financing To Advance Lead Shingles Candidate 10/15/2014 8:27:20 AM
Transcept Pharmaceuticals, Inc. (TSPT) Declares Special Dividend Of $12.79 Million And Additional Contingent Future Amounts In Connection With Its Merger With Paratek Pharmaceuticals, Inc. 10/15/2014 8:00:51 AM
1234567
//-->